MAPK8 and neuroblastoma: NSC697923, an inhibitor of the ubiquitin-conjugating enzyme E2 N, promoted NB cell death by regulating both p53 and JNK pathways, apoptosis induction, and colony formation inhibition in a dose-dependent manner across multiple MYCN-amplified and MYCN-non-amplified NB cell lines [29].